Inpatient clinical activities: Attending on Cardiology Ward Service, Attending on Arrhythmia Consult Service, Attending in Clinical Electrophysiology Laboratory, Cardiac Transplantation Cardiologist (October 1984-September 1987).
Outpatient clinical activities: Attending in Cardiology/Arrhythmia Clinic, Consultant for Sleep-Wake Disorders Center (1988-1991), Cardiac Transplantation Cardiologist (1984-1987).
Defibrillation and cardioversion; devices for the treatment of arrhythmias (implantable cardioverter-defibrillators, pacemakers); Electrophysiology and treatment of atrial and ventricular arrhythmias (interventional electrophysiology/ablation, surgical, pharmacologic); Clinical trials in arrhythmia treatment.
Selected Publications
Markman TM, Pothineni NVK, Zhgaib T, Smietana J, McBride D, Amankwah NA, Linn KA, Kumareswaran R, Hyman M, Arkles J, Santangeli P, Schaller RD, Supple GE, Frankel DS, Deo R, Lin D, Riley MP, EPSTEIN AE, Callans DJ, Marchlinski FE, Hamilton R, Nazarian S.: Transcutaneous magnetic stimulation to treat ventricular tachycardia storm: a randomized clinical trial. JAMA Cardiology Page: doi:10.1001/jamacardio.2021.6000, 2022.
Cairns JA, Healey JS, EPSTEIN AE, Themeles E, Balasubramanian K, Connolly SJ.: Prospective long-term follow-up of silicone-polyurethane-insulated implantable cardioverter defibrillator leads. Heart Rhythm O2 3: 57-64, 2022.
Lin AN, Peng G, Pothineni NVK, Winn SP, Hall SN, Deo R, Riley M, EPSTEIN AE, Arkles J, Dixit S.: Race does not provide protection from new onset atrial fibrillation after typical flutter ablation in male veteran patients. J Am Coll Cardiol EP Page: 1312-1314, October 2021.
Pothineni NVK, Lin A, Frankel DS, Supple GE, Garcia FC, Lin D, Hyman MC, Kumareswaran R, Arkles J, Riley M, Deo R, EPSTEIN AE, Nazarian S, Schaller RD, Callans DJ, Marchlinski FE, Santangeli P, Dixit S. : Impact of left atrial posterior wall ablation on arrhythmia outcomes in patients with atrial fibrillation undergoing repeat ablation. Heart Rhythm O2 2: 489-497, 2021.
Markman T, Smietana J, EPSTEIN AE. : A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change. Heart Rhythm Case Reports 7: 562-265, 2021.
Peng G, Lin AN, Obeng-Gyimah E, Hall SN, Yang YW, Chen S, Riley MP, Deo R, Ali A, Arkles J, EPSTEIN AE, Dixit S.: Implantable loop recorder for augmenting detection of new onset atrial fibrillation after typical atrial flutter ablation. Heart Rhythm O2(2), 255-261, 2021.
Kuo L, Muser D, Shirai Y, Lin A, Liang JJ, Schaller RD, Hyman MD, Kumareswaran R, Arkles J, Supple GE, Frankel DS, Garcia FC, Tschabrunn C, Nazarian S, Dixit S, Lin D, Riley MP, Callans DJ, Deo R, EPSTEIN AE, Zado ES, Marchlinski FE, Santangeli P. : Periprocedureal acute kidney injury in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia: incidence, predictors and impact on outcomes. J Am Coll Cardio EP 7: 174-186, 2021.
Markman TM, Brown CR, Yang L, Guandalini GS, Hyman MC, Arkles JS, Santangeli P, Schaller RD, Supple GE, Deo R, Nazarian S, Dixit S, Callans DJ, EPSTEIN AE, Marchlinski FE, Groeneveld PW, Frankel DS.: Persistent opioid use after cardiac implantable electronic device procedures. Circulation 144: 1590-1597, 2021.
Bhatla A, Borovskiy Y, Katz R, Hyman MC, Patel PJ, Arkles J, Callans DJ, Chokshi N, Dixit S, EPSTEIN AE, Frankel DS, Garcia FC, Kumareswaram R, Liang JJ, Lin D, Messé SR, Nazarian S, Riley MP, Santangeli P, Schaller RD, Supple GE, Kasner SE, Marchlinski FE, Deo R.: Stroke, timing of atrial fibrillation diagnosis, and risk of death. Neurology 96: e1655-e1662, 2021.
Schaller RD, Giri J, EPSTEIN AE.: Entrapped leads after transcatheter tricuspid valve replacement. J Am Coll Cardiovasc Intv 14: 715-716, 2021.
back to top
Last updated: 05/05/2022
The Trustees of the University of Pennsylvania
